证券日报网讯花园生物（300401）8月12日在互动平台回答投资者提问时表示，截至2025年8月8日，公 司股东总户数为27，029户。 ...

证券日报网讯花园生物（300401）8月5日在互动平台回答投资者提问时表示，截至2025年7月31日公司 股东总户数为26398户。 ...

证券日报网讯花园生物8月5日在互动平台回答投资者提问时表示，根据中国证券登记结算有限公司深圳 分公司最新一期下发的股东名册，截至2025年7月31日，公司股东总户数为26，398户。 （文章来源：证券日报） ...

Core Viewpoint - The company, Huayuan Biological, is a major global producer of lanolin cholesterol and is committed to continuously optimizing its production processes and technologies to enhance its competitive advantage [2]. Company Summary - Huayuan Biological is recognized as one of the leading producers of lanolin cholesterol globally [2]. - The company is focused on improving its production techniques and technological capabilities [2].

证券日报网讯花园生物（300401）8月5日在互动平台回答投资者提问时表示，公司已预约2025年8月16 日披露2025年半年度报告。 ...

Group 1 - The company Garden Biologics (300401.SZ) is a major producer of lanolin cholesterol and aims to continuously optimize its production processes and technology to enhance its competitive advantage [2] - The company has scheduled to disclose its semi-annual report for 2025 on August 16, 2025, which investors are encouraged to monitor for further insights [2]

Report Summary - The report lists the top ten convertible bonds for August 2025, providing detailed information about each bond, including issuer profiles, financial data, and company highlights [16][25][37] Company Highlights 1. Zhongte Convertible Bond - The company is a globally leading specialized special steel material manufacturer with a production capacity of approximately 20 million tons of special steel materials per year. It has a comprehensive strategic layout along the coastal and riverside areas [16]. - In 2024, its operating income was 109.203 billion yuan (YoY -4.22%), and the net profit attributable to the parent company was 5.126 billion yuan (YoY -10.41%). In Q1 2025, the operating income was 26.84 billion yuan (YoY -5.59%), and the net profit attributable to the parent company was 1.384 billion yuan (YoY +1.76%) [16]. - Company highlights include being one of the world's most comprehensive special steel enterprises in terms of variety and specifications, having a complete industrial chain, and actively seeking external expansion opportunities [17]. 2. Shanlu Convertible Bond - The company's main business is road and bridge engineering construction and maintenance, and it actively expands into other fields. It has a complete business and management system and can provide one - stop comprehensive services [25]. - In 2024, its operating income was 71.348 billion yuan (YoY -2.3%), and the net profit attributable to the parent company was 2.322 billion yuan (YoY +1.47%). In Q1 2025, the operating income was 9.764 billion yuan (YoY +1.95%), and the net profit attributable to the parent company was 249 million yuan (YoY +1.89%) [25]. - Company highlights include having the concept of "China - Special Valuation," potential improvements in the balance sheet and order volume in the context of debt resolution, expected benefits from regional infrastructure plans, and seizing opportunities under the Belt and Road Initiative [26]. 3. Hebang Convertible Bond - The company has advantages in resource reserves and product diversification, covering the chemical, agricultural, and photovoltaic industries [37]. - In 2024, its operating income was 8.547 billion yuan (YoY -3.13%), and the net profit attributable to the parent company was 31 million yuan (YoY -97.55%). In Q1 2025, the operating income was 1.726 billion yuan (YoY -13.68%), and the net profit attributable to the parent company was 13 million yuan (YoY -57.99%) [37]. - Company highlights include significant contributions from phosphate mines and stable profitability of salt mines, as well as high - margin liquid methionine production [38]. 4. Aima Convertible Bond - The company is a leading enterprise in the electric two - wheeler industry, with self - developed and produced products sold through dealers [47]. - In 2024, its operating income was 21.606 billion yuan (YoY +2.71%), and the net profit attributable to the parent company was 1.988 billion yuan (YoY +5.68%). In Q1 2025, the operating income was 6.232 billion yuan (YoY +25.82%), and the net profit attributable to the parent company was 605 million yuan (YoY +25.12%) [47]. - Company highlights include potential benefits from government subsidies, expected policy support after the implementation of new national standards, and room for improvement in gross margin [48]. 5. Industrial Convertible Bond - The company is one of the first joint - stock commercial banks in China and has evolved into a modern financial service group [57]. - In 2024, its operating income was 212.226 billion yuan (YoY +0.66%), and the net profit attributable to the parent company was 77.205 billion yuan (YoY +0.12%). In Q1 2025, the operating income was 55.683 billion yuan (YoY -3.58%), and the net profit attributable to the parent company was 23.796 billion yuan (YoY -2.22%) [57]. - Company highlights include stable growth in net interest income, stable asset quality, and continuous expansion of scale and customer base [58]. 6. Youfa Convertible Bond - The company is the largest welded steel pipe R & D, production, and sales enterprise in China, with a wide range of products used in multiple fields [70]. - In 2024, its operating income was 54.822 billion yuan (YoY -10.01%), and the net profit attributable to the parent company was 425 million yuan (YoY -25.46%). In Q1 2025, the operating income was 11.402 billion yuan (YoY +6.06%), and the net profit attributable to the parent company was 133 million yuan (YoY +9680.17%) [70]. - Company highlights include national layout and leading position in the industry, active exploration of overseas markets, and high - dividend distribution [71]. 7. Chongqing Bank Convertible Bond - The company is an early local joint - stock commercial bank in the upper reaches of the Yangtze River and Southwest China, with a wide range of business scopes [82]. - In 2024, its operating income was 13.679 billion yuan (YoY +3.54%), and the net profit attributable to the parent company was 5.117 billion yuan (YoY +3.8%). In Q1 2025, the operating income was 3.581 billion yuan (YoY +5.3%), and the net profit attributable to the parent company was 1.624 billion yuan (YoY +5.33%) [82]. - Company highlights include the development opportunities brought by the Chengdu - Chongqing Twin - City Economic Circle strategy, stable growth of asset scale, and active adjustment of credit strategies according to national policies [83]. 8. Tianye Convertible Bond - The company is a leading enterprise in the chlor - alkali chemical industry in China, with an integrated circular economy industrial chain [94]. - In 2024, its operating income was 11.156 billion yuan (YoY -2.7%), and the net profit attributable to the parent company was 68 million yuan (YoY +108.83%). In Q1 2025, the operating income was 2.417 billion yuan (YoY +8.17%), and the net profit attributable to the parent company was - 17 million yuan (YoY +89.97%) [94]. - Company highlights include relatively stable production costs of caustic soda flakes and plans to increase dividend frequency and advance coal mine projects [95]. 9. Huayuan Convertible Bond - The company focuses on building a complete vitamin D3 upstream - downstream industrial chain and aims to become a world - leading producer of related products [105]. - In 2024, its operating income was 1.243 billion yuan (YoY +13.58%), and the net profit attributable to the parent company was 309 million yuan (YoY +60.76%). In Q1 2025, the operating income was 326 million yuan (YoY -1.18%), and the net profit attributable to the parent company was 97 million yuan (YoY +5.5%) [105]. - Company highlights include leading products in the market, smooth progress of project construction, and expansion into other vitamin product categories [106]. 10. Yushui Convertible Bond - The company is the largest integrated water supply and drainage enterprise in Chongqing, with a stable monopoly position in the local market [116]. - In 2024, its operating income was 6.999 billion yuan (YoY -3.52%), and the net profit attributable to the parent company was 785 million yuan (YoY -27.88%). In Q1 2025, the operating income was 1.652 billion yuan (YoY +8.66%), and the net profit attributable to the parent company was 237 million yuan (YoY +28.91%) [116]. - Company highlights include high market share, continuous expansion of business scope, and effective cost control through intelligent applications [117].

| 证券代码：300401 | 证券简称：花园生物 | 公告编号：2025-022 | | --- | --- | --- | | 债券代码：123178 | 债券简称：花园转债 | | 浙江花园生物医药股份有限公司 关于 2025 年第二季度可转换公司债券转股情况公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 重要内容提示： 2、2025年第二季度，共有70张"花园转债"完成转股（票面金额共计人民币7,000.00 元），合计转成517股"花园生物"股票（证券代码：300401）。 3、截至2025年第二季度末，"花园转债"剩余债券张数为11,760,191张，剩余票面 总额为人民币1,176,019,100.00元。 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易所上市公司自律监 管指引第15号——可转换公司债券》的有关规定，浙江花园生物医药股份有限公司（以 下简称"公司"）现将2025年第二季度可转换公司债券（以下简称"可转债"）转股及 公司股份变化情况公告如下： 一、可转换公司债券基本情况 1、"花园转债"（债券代码：123178）转股 ...

| 证券代码：300401 | 证券简称：花园生物 | 公告编号：2025-020 | | --- | --- | --- | | 债券代码：123178 | 债券简称：花园转债 | | 浙江花园生物医药股份有限公司 第七届董事会第十次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏 浙江花园生物医药股份有限公司（以下简称"公司"）第七届董事会第十次会议于 2025年6月20日以通讯表决方式召开。会议通知于2025年6月16日以邮件、电子通讯等方 式送达给全体董事。本次会议应参加表决董事9人，实际参加表决董事9人。公司监事、 高管参与了会议。会议符合《中华人民共和国公司法》与《公司章程》的有关规定。 一、审议通过了《关于为全资子公司向银行申请授信额度提供担保的议案》 董事会认为本次担保事项风险可控，不存在损害公司及全体股东利益的情形。具体 内容详见巨潮资讯网（http://www.cninfo.com.cn）上披露的相关公告。 表决结果：同意9票，反对0票，弃权0票。本议案获得通过。 特此公告。 浙江花园生物医药股份有限公司董事会 2025年6月20 ...

| 证券代码：300401 | 证券简称：花园生物 公告编号：2025-019 | | --- | --- | | 债券代码：123178 | 债券简称：花园转债 | 浙江花园生物医药股份有限公司 关于为全资子公司向银行申请授信额度提供担保的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏 浙江花园生物医药股份有限公司（以下简称"公司"）于2025年6月20日召开的第 七届董事会第十次会议、第七届监事会第七次会议分别审议通过了《关于为全资子公司 向银行申请授信额度提供担保的议案》。现将有关事项公告如下： 一、担保情况概述 为支持公司全资子公司浙江花园药业有限公司（以下简称"花园药业"）业务发展和 经营资金需求，公司同意拟为花园药业向银行申请授信提供总额度合计不超过人民币 30,000万元的连带责任信用担保（实际担保金额、种类、期限等以最终担保合同为准）， 占公司最近一期经审计净资产的9.32%。以上担保额度自董事会审议通过之日起一年内有 效，董事会授权公司董事长在上述额度范围内签署担保事项的相关法律文件。 根据《深圳证券交易所创业板股票上市规则》《公司章程》等相关 ...